001     298615
005     20250216015206.0
024 7 _ |a 10.1126/sciimmunol.adp6667
|2 doi
024 7 _ |a pmid:39919199
|2 pmid
024 7 _ |a altmetric:173952312
|2 altmetric
037 _ _ |a DKFZ-2025-00315
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Lutz, Raphael
|0 P:(DE-He78)53d468db18d46cfda7d52f2af015c9ec
|b 0
|e First author
245 _ _ |a Bone marrow breakout lesions act as key sites for tumor-immune cell diversification in multiple myeloma.
260 _ _ |a Washington, DC
|c 2025
|b AAAS
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1739198460_5253
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a #EA:A010#EA:A360#LA:A360#
520 _ _ |a The bone marrow microenvironment plays a crucial role in the development of multiple myeloma. As the disease progresses, malignant myeloma cells can evolve to survive outside the bone marrow. However, the processes underlying bone marrow independence and their consequences for immune control remain poorly understood. Here, we conducted single-cell and spatial multiomics analyses of bone marrow-confined intramedullary disease and paired breakout lesions that disrupt the cortical bone. These analyses revealed a distinct cellular microenvironment and architectural features of breakout lesions, characterized by extensive areas of malignant plasma cells interspersed with lesion-specific solitary natural killer and macrophage populations, as well as focal accumulations of immune cell agglomerates. Within these agglomerates, spatially confined T cell clones expanded alongside various immune cells, coinciding with the local genomic evolution of tumor cells. These analyses identify breakout lesions as a hotspot for tumor-immune cell interactions and diversification, representing a key event in myeloma pathogenesis.
536 _ _ |a 311 - Zellbiologie und Tumorbiologie (POF4-311)
|0 G:(DE-HGF)POF4-311
|c POF4-311
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 2 |a Multiple Myeloma: immunology
|2 MeSH
650 _ 2 |a Multiple Myeloma: pathology
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Tumor Microenvironment: immunology
|2 MeSH
650 _ 2 |a Bone Marrow: immunology
|2 MeSH
650 _ 2 |a Bone Marrow: pathology
|2 MeSH
700 1 _ |a Poos, Alexandra
|0 P:(DE-He78)b06e4e56845c7f91bd749bb7e6ac9d51
|b 1
|e First author
|u dkfz
700 1 _ |a Solé-Boldo, Llorenç
|0 0000-0002-6974-9066
|b 2
700 1 _ |a John, Lukas
|0 P:(DE-He78)2ffc015bc2bdd9ed7a54d29dc063ab75
|b 3
|e First author
|u dkfz
700 1 _ |a Wagner, Johanna
|0 P:(DE-He78)3a561ce91c458fcb95955965df16d8b8
|b 4
|u dkfz
700 1 _ |a Prokoph, Nina
|0 P:(DE-He78)946ca014101d998e7e9f92290d48915c
|b 5
|u dkfz
700 1 _ |a Baertsch, Marc A
|0 0000-0002-4000-6904
|b 6
700 1 _ |a Vonficht, Dominik
|0 P:(DE-He78)115c5982c54d9819ae80acb0e140a21e
|b 7
700 1 _ |a Palit, Subarna
|b 8
700 1 _ |a Brobeil, Alexander
|b 9
700 1 _ |a Mechtersheimer, Gunhild
|0 0000-0002-9442-3930
|b 10
700 1 _ |a Hildenbrand, Nina
|b 11
700 1 _ |a Hemmer, Stefan
|0 0009-0000-8696-2099
|b 12
700 1 _ |a Steiger, Simon
|0 P:(DE-He78)2d16262c9228b5654242a4115a7bfc53
|b 13
|u dkfz
700 1 _ |a Horn, Sabrina
|b 14
700 1 _ |a Pepke, Wojciech
|0 0000-0001-9690-4511
|b 15
700 1 _ |a Spranz, David M
|b 16
700 1 _ |a Rehnitz, Christoph
|b 17
700 1 _ |a Sant, Pooja
|0 P:(DE-He78)0178c28b2dee9e8a977975ba9ff006e2
|b 18
|u dkfz
700 1 _ |a Mallm, Jan-Philipp
|0 P:(DE-He78)697cb039ca08f3b7e5a2a52dbf020b46
|b 19
|u dkfz
700 1 _ |a Friedrich, Mirco J
|b 20
700 1 _ |a Reichert, Philipp
|b 21
700 1 _ |a Huhn, Stefanie
|b 22
700 1 _ |a Trumpp, Andreas
|0 P:(DE-He78)732f4fbcddb0042251aa759a2e74d3b2
|b 23
|u dkfz
700 1 _ |a Rippe, Karsten
|0 P:(DE-He78)94de5f7413279464b6e738d91dfae1eb
|b 24
|u dkfz
700 1 _ |a Haghverdi, Laleh
|b 25
700 1 _ |a Fröhling, Stefan
|0 P:(DE-He78)f0144d171d26dbedb67c9db1df35629d
|b 26
700 1 _ |a Müller-Tidow, Carsten
|b 27
700 1 _ |a Hübschmann, Daniel
|0 P:(DE-He78)a5218e4871866cd5ab2312e594ca403d
|b 28
|u dkfz
700 1 _ |a Goldschmidt, Hartmut
|b 29
700 1 _ |a Willimsky, Gerald
|0 P:(DE-He78)bc039c65f54568c14d4aca488c101452
|b 30
|u dkfz
700 1 _ |a Sauer, Sandra
|b 31
700 1 _ |a Raab, Marc S
|0 P:(DE-He78)1cb537e833afd985097ccfaddffb2ef3
|b 32
|u dkfz
700 1 _ |a Haas, Simon
|0 P:(DE-He78)a5ec4e2fef99022a37a6b07c2fdd6325
|b 33
700 1 _ |a Weinhold, Niels
|0 P:(DE-He78)66b39a79f3f922997656d7b902d324fb
|b 34
|e Last author
|u dkfz
773 _ _ |a 10.1126/sciimmunol.adp6667
|g Vol. 10, no. 104, p. eadp6667
|0 PERI:(DE-600)2862556-0
|n 104
|p eadp6667
|t Science immunology
|v 10
|y 2025
|x 2470-9468
909 C O |o oai:inrepo02.dkfz.de:298615
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)53d468db18d46cfda7d52f2af015c9ec
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)b06e4e56845c7f91bd749bb7e6ac9d51
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-He78)2ffc015bc2bdd9ed7a54d29dc063ab75
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 4
|6 P:(DE-He78)3a561ce91c458fcb95955965df16d8b8
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 5
|6 P:(DE-He78)946ca014101d998e7e9f92290d48915c
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 6
|6 0000-0002-4000-6904
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 7
|6 P:(DE-He78)115c5982c54d9819ae80acb0e140a21e
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 13
|6 P:(DE-He78)2d16262c9228b5654242a4115a7bfc53
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 18
|6 P:(DE-He78)0178c28b2dee9e8a977975ba9ff006e2
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 19
|6 P:(DE-He78)697cb039ca08f3b7e5a2a52dbf020b46
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 23
|6 P:(DE-He78)732f4fbcddb0042251aa759a2e74d3b2
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 24
|6 P:(DE-He78)94de5f7413279464b6e738d91dfae1eb
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 26
|6 P:(DE-He78)f0144d171d26dbedb67c9db1df35629d
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 28
|6 P:(DE-He78)a5218e4871866cd5ab2312e594ca403d
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 30
|6 P:(DE-He78)bc039c65f54568c14d4aca488c101452
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 32
|6 P:(DE-He78)1cb537e833afd985097ccfaddffb2ef3
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 33
|6 P:(DE-He78)a5ec4e2fef99022a37a6b07c2fdd6325
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 34
|6 P:(DE-He78)66b39a79f3f922997656d7b902d324fb
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-311
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Zellbiologie und Tumorbiologie
|x 0
914 1 _ |y 2025
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b SCI IMMUNOL : 2022
|d 2024-12-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2024-12-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2024-12-17
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-17
915 _ _ |a IF >= 20
|0 StatID:(DE-HGF)9920
|2 StatID
|b SCI IMMUNOL : 2022
|d 2024-12-17
920 2 _ |0 I:(DE-He78)A360-20160331
|k A360
|l KKE Mol. Hämatologie/Onkologie
|x 0
920 1 _ |0 I:(DE-He78)A010-20160331
|k A010
|l A010 Stammzellen und Krebs
|x 0
920 1 _ |0 I:(DE-He78)A360-20160331
|k A360
|l KKE Mol. Hämatologie/Onkologie
|x 1
920 1 _ |0 I:(DE-He78)B340-20160331
|k B340
|l Translationale Medizinische Onkologie
|x 2
920 1 _ |0 I:(DE-He78)B066-20160331
|k B066
|l B066 Chromatin-Netzwerke
|x 3
920 1 _ |0 I:(DE-He78)W192-20160331
|k W192
|l Single-cell Open Lab
|x 4
920 1 _ |0 I:(DE-He78)HD01-20160331
|k HD01
|l DKTK HD zentral
|x 5
920 1 _ |0 I:(DE-He78)BE01-20160331
|k BE01
|l DKTK Koordinierungsstelle Berlin
|x 6
920 1 _ |0 I:(DE-He78)W015-20160331
|k W015
|l Innovations- und Service-Unit für Bioinformatik und Präzisionsmedizin
|x 7
920 0 _ |0 I:(DE-He78)A010-20160331
|k A010
|l A010 Stammzellen und Krebs
|x 0
920 0 _ |0 I:(DE-He78)A360-20160331
|k A360
|l KKE Mol. Hämatologie/Onkologie
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)A010-20160331
980 _ _ |a I:(DE-He78)A360-20160331
980 _ _ |a I:(DE-He78)B340-20160331
980 _ _ |a I:(DE-He78)B066-20160331
980 _ _ |a I:(DE-He78)W192-20160331
980 _ _ |a I:(DE-He78)HD01-20160331
980 _ _ |a I:(DE-He78)BE01-20160331
980 _ _ |a I:(DE-He78)W015-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21